Globus Medical Stock Performance
GMED Stock | USD 49.79 0.82 1.62% |
The company retains a Market Volatility (i.e., Beta) of 0.11, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Globus Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Globus Medical is expected to be smaller as well. Globus Medical has an expected return of -0.0735%. Please make sure to check out Globus Medical kurtosis, and the relationship between the value at risk and rate of daily change , to decide if Globus Medical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Globus Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Globus Medical is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Actual Historical Performance (%)
One Day Return (1.62) | Five Day Return (3.02) | Year To Date Return (6.34) | Ten Year Return 103.89 | All Time Return 268.81 |
1 | Compared to Estimates, Globus Medical Q4 Earnings A Look at Key Metrics | 02/21/2024 |
2 | An Intrinsic Calculation For Globus Medical, Inc. Suggests Its 42 percent Undervalued | 04/08/2024 |
3 | Globus Medical, Inc. Receives Average Rating of Moderate Buy from Brokerages - Defense World | 04/11/2024 |
4 | Why Globus Medical is a Top Momentum Stock for the Long-Term | 04/15/2024 |
5 | SMAIO publie ses rsultats annuels 2023 | 04/16/2024 |
6 | Office of Health Economics Impfprogramme fr Erwachsene bieten bis zu 19-fachen soziokonomischen Mehrwert gegenber ursprnglicher Investition so ein neuer Bericht | 04/17/2024 |
7 | Taylor Swift joins the ranks of Pennsylvanias billionaires. See how much theyre worth | 04/18/2024 |
8 | GMED vs. PEN Which Stock Is the Better Value Option | 04/23/2024 |
9 | MiLaboratories und Miltenyi Biotec kndigen strategische Partnerschaft an, um Therapien der nchsten Generation voranzutreiben | 04/29/2024 |
Begin Period Cash Flow | 150.5 M |
Globus |
Globus Medical Relative Risk vs. Return Landscape
If you would invest 5,248 in Globus Medical on February 1, 2024 and sell it today you would lose (269.00) from holding Globus Medical or give up 5.13% of portfolio value over 90 days. Globus Medical is currently does not generate positive expected returns and assumes 1.507% risk (volatility on return distribution) over the 90 days horizon. In different words, 13% of stocks are less volatile than Globus, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
Globus Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Globus Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Globus Medical, and traders can use it to determine the average amount a Globus Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0488
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | GMED |
Estimated Market Risk
1.51 actual daily | 13 87% of assets are more volatile |
Expected Return
-0.07 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Globus Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Globus Medical by adding Globus Medical to a well-diversified portfolio.
Globus Medical Fundamentals Growth
Globus Stock prices reflect investors' perceptions of the future prospects and financial health of Globus Medical, and Globus Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Globus Stock performance.
Return On Equity | 0.0421 | ||||
Return On Asset | 0.0477 | ||||
Profit Margin | 0.08 % | ||||
Operating Margin | 0.13 % | ||||
Current Valuation | 6.85 B | ||||
Shares Outstanding | 112.62 M | ||||
Price To Earning | 73.16 X | ||||
Price To Book | 1.75 X | ||||
Price To Sales | 4.46 X | ||||
Revenue | 1.57 B | ||||
Gross Profit | 759.12 M | ||||
EBITDA | 401.03 M | ||||
Net Income | 122.87 M | ||||
Cash And Equivalents | 408.01 M | ||||
Cash Per Share | 4.10 X | ||||
Total Debt | 520.4 M | ||||
Debt To Equity | 0 % | ||||
Current Ratio | 6.10 X | ||||
Book Value Per Share | 29.32 X | ||||
Cash Flow From Operations | 243.5 M | ||||
Earnings Per Share | 1.07 X | ||||
Market Capitalization | 6.84 B | ||||
Total Asset | 5.09 B | ||||
Retained Earnings | 1.14 B | ||||
Working Capital | 1.52 B | ||||
Current Asset | 544.8 M | ||||
Current Liabilities | 82.69 M | ||||
About Globus Medical Performance
To evaluate Globus Medical Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Globus Medical generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Globus Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Globus Medical market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Globus's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Last Reported | Projected for Next Year | ||
Days Of Inventory On Hand | 564.73 | 592.96 | |
Return On Tangible Assets | 0.05 | 0.04 | |
Return On Capital Employed | 0.03 | 0.03 | |
Return On Assets | 0.02 | 0.02 | |
Return On Equity | 0.03 | 0.03 |
Things to note about Globus Medical performance evaluation
Checking the ongoing alerts about Globus Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Globus Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Globus Medical generated a negative expected return over the last 90 days | |
Over 97.0% of the company shares are owned by institutional investors | |
Latest headline from businesswire.com: MiLaboratories und Miltenyi Biotec kndigen strategische Partnerschaft an, um Therapien der nchsten Generation voranzutreiben |
- Analyzing Globus Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Globus Medical's stock is overvalued or undervalued compared to its peers.
- Examining Globus Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Globus Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Globus Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Globus Medical's stock. These opinions can provide insight into Globus Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.Note that the Globus Medical information on this page should be used as a complementary analysis to other Globus Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Globus Stock analysis
When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Transaction History View history of all your transactions and understand their impact on performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |
Is Globus Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.79) | Earnings Share 1.07 | Revenue Per Share 13.87 | Quarterly Revenue Growth 1.246 | Return On Assets 0.0477 |
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.